Kambiz Yazdi
Stock Analyst at BTIG
(4.60)
# 886
Out of 4,455 analysts
59
Total ratings
68.8%
Success rate
31.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABSI Absci | Maintained: Buy | $9 → $13 | $10.89 | +19.38% | 2 | Jun 24, 2026 | |
| ZVRA Zevra Therapeutics | Reiterated: Buy | $23 → $27 | $13.52 | +99.70% | 3 | Jun 9, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Buy | $843 → $810 | $327.79 | +147.11% | 14 | Jun 2, 2026 | |
| RAPP Rapport Therapeutics | Maintained: Buy | $65 | $40.06 | +62.26% | 7 | Jun 1, 2026 | |
| VTVT vTv Therapeutics | Maintained: Buy | $49 | $34.95 | +40.20% | 6 | May 13, 2026 | |
| SION Sionna Therapeutics | Rated: Buy | $58 | $42.18 | +37.51% | 7 | May 12, 2026 | |
| BME: PHM Pharma Mar, S.A. | Initiated Coverage: Buy | €121.00 | $73.00 | +65.75% | 1 | Apr 23, 2026 | |
| ARQT Arcutis Biotherapeutics | Maintained: Buy | $31 | $27.00 | +14.81% | 6 | Jan 15, 2026 | |
| LQDA Liquidia | Reiterated: Buy | $27 → $31 | $78.17 | n/a | 6 | May 28, 2025 | |
| AVTX Avalo Therapeutics | Initiated Coverage: Buy | $23 | $18.20 | n/a | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $13.66 | n/a | 1 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.19 | n/a | 1 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $14 | $0.323 | n/a | 3 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.0081 | n/a | 1 | May 31, 2023 |
Absci
Jun 24, 2026
Maintained: Buy
Price Target: $9 → $13
Current: $10.89
Upside: +19.38%
Zevra Therapeutics
Jun 9, 2026
Reiterated: Buy
Price Target: $23 → $27
Current: $13.52
Upside: +99.70%
Praxis Precision Medicines
Jun 2, 2026
Maintained: Buy
Price Target: $843 → $810
Current: $327.79
Upside: +147.11%
Rapport Therapeutics
Jun 1, 2026
Maintained: Buy
Price Target: $65
Current: $40.06
Upside: +62.26%
vTv Therapeutics
May 13, 2026
Maintained: Buy
Price Target: $49
Current: $34.95
Upside: +40.20%
Sionna Therapeutics
May 12, 2026
Rated: Buy
Price Target: $58
Current: $42.18
Upside: +37.51%
Pharma Mar, S.A.
Apr 23, 2026
Initiated Coverage: Buy
Price Target: €121.00
Current: $73.00
Upside: +65.75%
Arcutis Biotherapeutics
Jan 15, 2026
Maintained: Buy
Price Target: $31
Current: $27.00
Upside: +14.81%
Liquidia
May 28, 2025
Reiterated: Buy
Price Target: $27 → $31
Current: $78.17
Upside: n/a
Avalo Therapeutics
Mar 25, 2025
Initiated Coverage: Buy
Price Target: $23
Current: $18.20
Upside: n/a
Aug 28, 2024
Maintained: Buy
Price Target: $15
Current: $13.66
Upside: n/a
Apr 11, 2024
Initiated Coverage: Buy
Price Target: $5
Current: $1.19
Upside: n/a
Mar 7, 2024
Maintained: Buy
Price Target: $15 → $14
Current: $0.323
Upside: n/a
May 31, 2023
Upgraded: Buy
Price Target: $7
Current: $0.0081
Upside: n/a